Lina Alami

Dr. Lina Alami

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2026
Verified
Book Chapter
Open access
PDF file
BBBhavneet Singh Bhalla
Bhavneet Singh Bhalla
Murtaja SateaMurtaja Satea
Murtaja Satea
Adolfo Pérez BonetAdolfo Pérez Bonet
Adolfo Pérez Bonet
VBValeria Atenea Costa Barney
Valeria Atenea Costa Barney
Christian Adrian Macias ArguelloChristian Adrian Macias Arguello
Christian Adrian Macias Arguello
PSPavit Singh
Pavit Singh
Artificial intelligence (AI) is increasingly influencing the field of endo-bariatrics by bringing greater precision, personalization, and efficiency to the management of obesity and metabolic diseases. This chapter examines how AI can be integrated across endoscopic bariatric and metabolic therapies (EBMTs from patient selection, to pre-procedure planning, intra-op support, and long-term follow-up. Traditionally, EBMT outcomes have often depended on the operator’s experience, which can lead to variability in results and a lack of standardized practice. AI technologies such as machine learning, deep learning, computer vision, and predictive analytics can help overcome these limitations by enabling more data-driven decisions, automatic recognition of anatomical structures, and real-time procedural support. In the pre-procedure stage, AI can assist with advanced imaging analysis, volumetric assessment, and simulation models that help clinicians plan individualized treatment strategies. During procedures, AI-assisted visualization systems, robotic support, depth sensing, and predictive tools for complications may improve procedural safety and consistency. Post-procedure, AI-enabled mobile applications and wearable device can allow continuous monitoring of patients, provide behavioral guidance, and help detect complications at an early stage, and improve long-term outcomes. Aditionally, AI may also improve workflow efficiency, reduce costs, standardize training, and help expand access to EBMTs. However, wider use of AI in endo-bariatrics faces several challenges such as concerns about data bias, lack of transparency, medico-legal responsibility, and unequal global access. Therefore, careful evaluation of AI systems is essential for safe implementation. AI has the potential to shift endo-bariatrics from a largely technique-dependent field to a more predictive, data-driven, and precision-based discipline.

18 November 2025 in Cancers
Verified
Journal Article
Open access
PDF file
Amine SouadkaAmine Souadka
Amine Souadka
Lina AlamiLina Alami
Lina Alami
ZMZakaria El Mouatassim
Zakaria El Mouatassim
OLOumayma Lahnaoui
Oumayma Lahnaoui
YBYassine El Bouazizi
Yassine El Bouazizi
BABrahim El Ahmadi
Brahim El Ahmadi
Background: Cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC) remains the standard of care for peritoneal surface malignancies but carries significant postoperative risks. In low- and middle-income countries (LMICs), the challenge is magnified by limited access to high-cost enhanced recovery programs. The SCODA (Surgical Complication Optimization through Diet and Activity) program was developed as a low-cost prehabilitation intervention to improve outcomes in resource-constrained settings. Methods: This retrospective cohort study included 169 patients undergoing CRS ± HIPEC at a single academic center in Morocco between 2015 and 2023. Patients treated before SCODA implementation (pre-SCODA group, n = 83) were compared to those enrolled in the SCODA program (SCODA group, n = 86). SCODA included oral iron supplementation, a protein-rich food-based diet, and progressive walking sessions over 90 days. Perioperative outcomes, including pulmonary complications, major morbidity (Clavien–Dindo ≥ 3b), transfusions, ICU stay >3 days, and 90-day mortality, were analyzed using univariate and multivariate logistic regression models. Results: The SCODA group had significantly fewer pulmonary complications (2% vs. 13%, p = 0.008), reduced major morbidity (9% vs. 21%, p = 0.031), fewer transfusions (8% vs. 20%, p = 0.024), and shorter ICU stays (median 1.5 vs. 5 days, p < 0.001). Ninety-day mortality was also lower in the SCODA group (5.8% vs. 12.4%, p = 0.046). SCODA participation remained an independent protective factor in multivariate analyses for all endpoints except major complications. Conclusions: The SCODA program is a feasible and effective prehabilitation strategy for improving surgical outcomes after CRS/HIPEC in LMICs. Its low-cost, food-based, and activity-centered design may support broader implementation in resource-limited environments and inform future perioperative care policies in oncology.